Boston Common Asset Management’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,771
| Closed | -$2.38M | – | 315 |
|
|
2024
Q1 | $2.38M | Sell |
25,771
-6,599
| -20% | -$609K | 0.06% | 252 |
|
|
2023
Q4 | $3.42M | Sell |
32,370
-120,620
| -79% | -$12.7M | 0.08% | 228 |
|
|
2023
Q3 | $16.6M | Sell |
152,990
-92,395
| -38% | -$10M | 0.4% | 96 |
|
|
2023
Q2 | $26.5M | Sell |
245,385
-19,257
| -7% | -$2.08M | 0.57% | 70 |
|
|
2023
Q1 | $33M | Sell |
264,642
-5,161
| -2% | -$643K | 0.69% | 49 |
|
|
2022
Q4 | $40.5M | Sell |
269,803
-10,084
| -4% | -$1.51M | 1.94% | 4 |
|
|
2022
Q3 | $37.8M | Sell |
279,887
-3,889
| -1% | -$525K | 1.98% | 4 |
|
|
2022
Q2 | $42.3M | Buy |
283,776
+3,595
| +1% | +$536K | 2.11% | 4 |
|
|
2022
Q1 | $47.8M | Buy |
280,181
+87,511
| +45% | +$14.9M | 2.06% | 6 |
|
|
2021
Q4 | $49.7M | Buy |
+192,670
| New | +$49.7M | 2.01% | 6 |
|